ArticleCancer research and treatment2019

Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients.

Hyery Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.